Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsMembrane proteins mediate processes that are fundamental for the flourishing of biological cells, playing critical roles in cellular function and therapeutic targets. Membrane-embedded transporters move ions and larger solutes across membranes; receptors mediate communication between the cell and its environment and membrane-embedded enzymes catalyze chemical reactions. One outstanding challenge is the difficulty in preparing a sufficient amount of these membrane proteins so as to be able to generate the functional antibody and conduct functional assays.
| Cat | Product Name | CAS Number | CMC in H2O | ||||
| MPD0025K | n-Octyl-β-D-Glucopyranoside (OG) | 29836-26-8 | 0.53% | ||||
| MPD0041K | n-Dodecyl-β-D-Maltopyranoside (DDM) | 69227-93-6 | 0.0087% | ||||
| MPD0044K | n-Decyl-β-D-Maltopyranoside (DM) | 82494-09-5 | 0.087% | ||||
| MPD0070K | Lauryl Maltose Neopentyl Glycol (LMNG) | 1257852-96-2 | 0.001% | ||||
| MPD0092K | CHAPS | 75621-03-3 | 0.49% | ||||
| MPD0182K | GDN | 1402423-29-3 | 0.0021% | ||||
| MPD0204K | Octaethylene Glycol Monododecyl Ether (C12E8) | 3055-98-9 | 0.0048% |
| Cat | Product Name | Classifications | CAS Number |
| MPL0001K | DPPC | Phosphatidylcholine (PC) | 63-89-8 |
| MPL0002K | DSPC | Phosphatidylcholine (PC) | 816-94-4 |
| MPL0005K | DOPC | Phosphatidylcholine (PC) | 4235-95-4 |
| MPL0006K | POPC | Phosphatidylcholine (PC) | 26853-31-6 |
| MPL0007K | DAPC | Phosphatidylcholine (PC) | 61596-53-0 |
| MPL0009K | DSPE | Phosphadylethanolamine (PE) | 1069-79-0 |
| MPL0089K | DSPG | Phosphatidylglycerol (PG) | 200880-42-8 |
| MPL0092K | DLPG | Phosphatidylglycerol (PG) | 322647-27-8 |
| MPL0093K | DSPA | Phosphatidic Acid (PA) | 108321-18-2 |
| MPL0096K | DLPA | Phosphatidic Acid (PA) | 108321-06-8 |
| MPL0097K | DOPA | Phosphatidic Acid (PA) | 108392-02-5 |
| MPL0098K | DPPS | Phosphatidylserine (PS) | 145849-32-7 |
| MPL0099K | DOTAP | Cationic Lipids | 132172-61-3 |
| Cat | Product Name | Species | Tag | Nanodiscs Size |
| MPN0001K | MSP1E3D1, His- | Streptomyces kanamyceticus | His tag at N-terminus | 12.9 nm in diameter |
| MPN0002K | MSP1D1, His- | Microbial | His tag at N-terminus | 9.7 nm in diameter |
| MPN0016K | MSP1D1 ∆H5, tag-free | Human | Tag-free | 7-8 nm in diameter |
| MPN0017K | MSP1D1, tag-free | Mouse | Tag-free | 9-10 nm in diameter |
| MPN0024K | MSP1E3D1, tag-free | Human | Tag-free | 12-14 nm in diameter |
| MPN0025K | MSP2N2, His | Human | His tag | 17 nm in diameter |
| Cat | Product Name | Molecular Formula | Formula Weight |
| MPP010K | Amphipol A8-35 | C6.2H10.3O1.35N0.65Na0.35)~72 | 9 kDa |
| MPP011K | Poly (Maleic Anhydride-alt-1-Decene) substituted with 3-(Dimethylamino) Propylamine | (C19H36O3N2)n | 18,500.00 |
| MPP012K | Poly (Maleic Anhydride-alt-1-Tetradecene) substituted with 3-(Dimethylamino) Propylamine | (C23H44O3N2)n | 12,000.00 |
| MPP013K | Poly (Maleic Anhydride-Alt-1-Octadecene) substituted with 3-(Dimethylamino) Propylamine | (C27H52O3N2)n | 39,000-65,000 |
| MPP014K | Biotinylated Amphipol A8-35 | C6.5H11.225O1.375N0.75Na0.325)~72 | 9.3 kDa |
| MPP015K | Poly (Maleic Anhydride-alt-1-Decene) substituted with 3-(Dimethylamino) Propylamine and Biotin ethylene diamine | (C19H36O3N2)n.(C26H43O5N4S)m | 18.5 kDa |
| MPP016K | Non-Ionic Amphipol A8-35 | C7H15O4SN (C31H54O15N2)n | 7000-35000g/mol |
| Detergent form | Liposome form | Nanodisc form | Polymer form |
|
|
|
|
All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.
